Lighthouse Pharmaceuticals reported raising $15.2 Million in an initial SEC Form D filing, from an offering of $15.2 Million
Round Type
Series A
Investors
Description
Lighthouse Pharmaceuticals, a Novato, CA-based clinical-stage biopharmaceutical company developing therapies for neurodegenerative diseases, raised $12M in Series A funding. The round was led by Double Point Ventures, which will see Campbell Murray, M.D., join the board. The funds will support the advancement of LHP588 and pipeline expansion. Lighthouse focuses on developing small-molecule therapeutics for Alzheimer's disease, among other conditions.
Quick answer
Lighthouse Pharmaceuticals raised $15.2 Million in a Series A round, dated April 22, 2026. Investors: Double Point Ventures.
- How much did Lighthouse Pharmaceuticals raise?
- Lighthouse Pharmaceuticals raised $15.2 Million in a Series A round on April 22, 2026.
- Who invested in Lighthouse Pharmaceuticals?
- Double Point Ventures is named as investors in this round.
- What does Lighthouse Pharmaceuticals do?
- Lighthouse Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel small-molecule therapeutics for chronic neurodegenerative and inflammatory diseases.
- Where is Lighthouse Pharmaceuticals based and how big is it?
- Fundz records about 11 employees.
- Who are the decision-makers at Lighthouse Pharmaceuticals?
- Fundz holds 1 contact at Lighthouse Pharmaceuticals, including the Head of CMC. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Lighthouse Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Citius Oncology raised $37M on May 6, 2026.
- Windward Bio raised $165M (Funding Round) on May 5, 2026.
- Tempest Therapeutics raised $4.1M on May 29, 2026.
- HCW Biologics raised $4M on May 21, 2026.
- AIM ImmunoTech raised $2.4M (Post-IPO Equity) on May 20, 2026.
- Acurx Pharmaceuticals raised $4.6M (Post-IPO Equity) on April 15, 2026.
Who to call at Lighthouse Pharmaceuticals, and when
A new round usually means Lighthouse Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lighthouse Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lighthouse Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lighthouse Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lighthouse Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansLighthouse Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.